Cheshire and Mersey Stroke Strategic Clinical Network in UK has integrated AI algorithms for stroke patients diagnosis in partnership with Wellbeing Software and Brainomix. AI algorithm is applied to analyze the brain scans, helping physicians to make faster and more informed decisions on ischemic stroke treatment options for patients.

Vice President of Healthcare Global at Brainomix Riaz Rahman assured that they are ready to provide “frontline stroke physicians with fast and critical clinical information to optimize treatment decisions in what is a highly time-sensitive pathway”. Clinical Director, Cheshire and Mersey Stroke Strategic Clinical Network Dr Nikhil Sharma has added that the software “will enable more patients than ever to access vital reperfusion therapies” that has “a huge lifesaving and disability-reducing impact”.

AI has a huge potential in cardiology. Last month, Brandon Fornwalt from Geisinger and his colleagues have revealed groundbreaking research findings, proving that their AI Model can predict patient death within a year better than practicing cardiologists, relying only on electrocardiogram results.

Yet AI tools are not limited to data analysis. This month Neurobotics has introduced a new robot-logopedist that can improve the communication between the therapist and patient and help patients recovering from stroke to restore their speech. The artificial head records the patient’s speech, analyses it with neural networks, creates suggestions for the recovering patient, and generates reports for the doctor, who can correct the treatment accordingly.

Director of Neurobotics Vladimir Konyshev shared that the company had to create their own AI algorithm, so it could interpret the speech from patients struggling to articulate works after strokes. Currently, the robot is undergoing tests at Lyadov Clinic in Moscow, while the commercial launch is expected in 2020 for a price of about $9500 for one robot.